Renxit is a combination medication containing Flupentixol (0.5 mg) and Melitracen (10 mg), manufactured by Renata Limited. It is primarily used to treat conditions such as anxiety, depression, apathy, psychogenic depression, depressive neuroses, masked depression, psychosomatic disorders accompanied by anxiety and apathy, menopausal depression, and dysphoria in alcoholics and drug addicts